Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 32,753,000 | 28,216,000 | 25,638,000 | 22,859,000 | 19,960,000 |
| Cost of Goods | 7,718,000 | 7,042,000 | 5,832,000 | 4,500,000 | 4,426,000 |
| Gross Profit | 25,035,000 | 21,174,000 | 19,806,000 | 18,359,000 | 15,534,000 |
| Operating Expenses | 18,652,000 | 11,629,000 | 10,466,000 | 10,822,000 | 12,123,000 |
| Operating Income | 6,383,000 | 9,545,000 | 9,340,000 | 7,537,000 | 3,411,000 |
| Interest Expense | 1,144,000 | 1,004,000 | 965,000 | 686,000 | 391,000 |
| Other Income | -42,000 | -814,000 | -491,000 | -206,000 | -651,000 |
| Pre-tax Income | 5,197,000 | 7,727,000 | 7,884,000 | 6,645,000 | 2,369,000 |
| Income Tax | -490,000 | 2,418,000 | 1,931,000 | 1,501,000 | 595,000 |
| Net Income Continuous | 5,687,000 | 5,309,000 | 5,953,000 | 5,144,000 | 1,774,000 |
| Net Income | $5,687,000 | $5,309,000 | $5,953,000 | $5,144,000 | $1,774,000 |
| EPS Basic Total Ops | 3.67 | 3.31 | 3.65 | 3.15 | 1.11 |
| EPS Basic Continuous Ops | 3.69 | 3.33 | 3.67 | 3.17 | 1.11 |
| EPS Diluted Total Ops | 3.66 | 3.30 | 3.63 | 3.13 | 1.10 |
| EPS Diluted Continuous Ops | 3.68 | 3.31 | 3.65 | 3.14 | 1.10 |
| EPS Diluted Before Non-Recurring Items | 7.91 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $8,148,000 | $11,046,000 | $10,529,000 | $8,373,000 | $4,197,000 |